4.1 Article

Ethnicity Disparities in the Prevalence, Awareness, Treatment, and Control Rates of Hypertension in China

期刊

INTERNATIONAL JOURNAL OF HYPERTENSION
卷 2023, 期 -, 页码 -

出版社

HINDAWI LTD
DOI: 10.1155/2023/1432727

关键词

-

向作者/读者索取更多资源

This study aimed to determine the prevalence, awareness, treatment, and control rates of hypertension in different Chinese ethnic groups. The findings revealed disparities in these rates among different ethnic populations, and identified several factors influencing these disparities.
Objectives. Previous studies reported that there were disparities in hypertension management among different ethnic groups, and this study aimed to systematically determine the prevalence, awareness, treatment, and control rates of hypertension in multiple Chinese ethnic groups. Methods. We searched Embase, PubMed, and Web of Science for articles up to 25 October, 2022. The pooled prevalence, awareness, treatment, and control rates of hypertension were estimated with 95% confidence intervals (CI). The heterogeneity of estimates among studies was assessed by the Cochran Q test and I-2 statistic. Meta-regression analyses were conducted to identify the factors influencing the heterogeneity of the pooled prevalence, awareness, treatment, and control rate of hypertension. Results. In total, 45 publications including 193,788 cases and 587,826 subjects were eligible for the analyses. The lowest prevalence was found in the Han group (27.0%), and the highest prevalence was in the Mongolian population (39.8%). The awareness rates ranged from 24.4% to 58.0% in the four ethnic groups. Both the highest treatment and control rates were found in the Mongolian population (50.6% and 16.0%, respectively), whereas the Yi group had the lowest control rate (8.0%). In addition, the study year, the mean age of subjects, mean body mass index of subjects, tobacco use (%), alcohol use (%), residence (urban%), and education (primary school%) had varied effects on heterogeneity. Conclusions. These findings highlight the disparities in prevalence, awareness, treatment, and control rates of hypertension in a different ethnic population of China, which could provide suggestions for making targeted prevention measures.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Hematology

Fibrin clot formation under diverse clotting conditions: Comparing turbidimetry and thromboelastography

Ziqian Zeng, Mahussi Fagnon, Tanmaye Nallan Chakravarthula, Nathan J. Alves

THROMBOSIS RESEARCH (2020)

Meeting Abstract Biochemistry & Molecular Biology

Effect of PEG Linker Length on Human Plasmin Inhibition by Benzamidine

Tanmaye Chakravarthula, Ziqian Zeng, Nathan Alves

FASEB JOURNAL (2020)

Article Multidisciplinary Sciences

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Ziqian Zeng, Tanmaye Nallan Chakravarthula, Nathan J. Alves

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2020)

Article Engineering, Biomedical

Design and Characterization of Biomimetic Kerateine Aerogel-Electrospun Polycaprolactone Scaffolds for Retinal Cell Culture

Ziqian Zeng, Phuong T. Lam, Michael L. Robinson, Katia Del Rio-Tsonis, Justin M. Saul

Summary: Researchers have designed a scaffold system mimicking the choroid and Bruch's membrane for the treatment of AMD, with elastic moduli similar to the native tissues. Cells attached to the polycaprolactone fibers, remained viable for one week, and proliferated to form a monolayer, making these constructs suitable for testing cell and/or drug treatment strategies for AMD.

ANNALS OF BIOMEDICAL ENGINEERING (2021)

Article Hematology

In-vitro thromboelastographic characterization of reconstituted whole blood utilizing cryopreserved platelets

Alexei Christodoulides, Ziqian Zeng, Nathan J. Alves

Summary: Conducting in-vitro thrombosis research presents challenges due to limited functional shelf-lives of blood products. Fractionating and recombining whole blood can prolong clotting functionality and improve accessibility in thrombosis research. Storage of fractionated whole blood components allows for prolonged usability and formation of clots resembling freshly drawn whole blood.

BLOOD COAGULATION & FIBRINOLYSIS (2021)

Article Endocrinology & Metabolism

Stabilization protects islet integrity during respirometry in the Oroboros Oxygraph-2K analyzer

Justin J. Crowder, Ziqian Zeng, Alissa N. Novak, Nathan J. Alves, Amelia K. Linnemann

Summary: Metabolic dysfunction of beta-cells contributes to diabetes pathogenesis. This study introduces a novel 3D-printed islet stabilization device to improve conventional Oxygraph respirometry of pancreatic islets by preserving natural islet structure and function.

ISLETS (2022)

Article Chemistry, Medicinal

Multivalent Benzamidine Molecules for Plasmin Inhibition: Effect of Valency and Linker Length

Tanmaye Nallan Chakravarthula, Ziqian Zeng, Nathan J. Alves

Summary: This study explores the effect of multivalent benzamidine inhibitors with varying valency and linker length on plasmin inhibition. The findings suggest that increasing valency and decreasing linker length can enhance the inhibition of plasmin, providing guidance for designing multivalent inhibitors.

CHEMMEDCHEM (2022)

Article Biotechnology & Applied Microbiology

Real-time tracking of fibrinolysis under constant wall shear and various pulsatile flows in an in-vitro thrombolysis model

Ziqian Zeng, Alexei Christodoulides, Nathan J. Alves

Summary: There is a need for a more representative in-vitro model to screen thrombolytic therapies. In this study, a flowing clot lysis platform with real-time fibrinolysis monitoring was designed and validated. The platform showed tPA-dependent thrombolysis and can be adapted to produce pulsatile flows, mimicking hemodynamics of human main pulmonary artery. These findings suggest that the platform offers a versatile testing platform for thrombolytic drug screening.

BIOENGINEERING & TRANSLATIONAL MEDICINE (2023)

Meeting Abstract Hematology

FABRICATION OF A PHYSIOLOGICALLY RELEVANT FLUORESCENTLY LABELED CLOT IN A CHANDLER LOOP

Ziqian Zeng, Alexei Christodoulides, Nathan J. Alves

AMERICAN JOURNAL OF HEMATOLOGY (2023)

Meeting Abstract Hematology

EVALUATION OF INHIBITORS EFFECT ON PLASMIN'S AMIDOLYTIC AND FIBRINOLYTIC ACTIVITY USING S-2251 AND ANNULAR FIBRIN CLOT ASSAYS

Tanmaye Nallan Chakravarthula, Liliana Patino, Ziqian Zeng, Nathan J. Alves

AMERICAN JOURNAL OF HEMATOLOGY (2023)

Meeting Abstract Hematology

CHARACTERIZING A PHYSIOLOGICALLY RELEVANT IN-VITRO THROMBOLYSIS MODEL UTILIZING FLUORESCENTLY LABELED CLOTS FORMED UNDER SHEAR

Alexei Christodoulides, Ziqian Zeng, Nathan J. Alves

AMERICAN JOURNAL OF HEMATOLOGY (2023)

Article Materials Science, Biomaterials

Fluorescently conjugated annular fibrin clot for multiplexed real-time digestion analysis

Ziqian Zeng, Tanmaye Nallan Chakravarthula, Charanya Muralidharan, Abigail Hall, Amelia K. Linnemann, Nathan J. Alves

Summary: The fluorescently labeled fibrin clot lysis assay introduced in this study uses a unique annular clot geometry and a microplate reader for detection. The optimized physiologically relevant clot substrate showed nearly physiological clot properties, making it suitable for evaluating patient fibrinolytic potential and screening thrombolytic drug activities in personalized medical applications.

JOURNAL OF MATERIALS CHEMISTRY B (2021)

Meeting Abstract Biochemistry & Molecular Biology

Modulating Plasmin Activity using Multivalent Benzamidine Inhibitors

Tanmaye Nallan Chakravarthula, Ziqian Zeng, Nathan Alves

FASEB JOURNAL (2021)

Letter Biochemistry & Molecular Biology

Equivalence Study of Semaxanib from Different Suppliers

Tanmaye Nallan Chakravarthula, John Zagorski, Ziqian Zeng, Jeffrey A. Kline, Nathan J. Alves

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2020)

暂无数据